Importantly, this mechanism is manifested in the breast cancer patient samples and TCGA database, which showed that low expression of SIRT1 in the tumor tissues compared with normal adjacent tissues and OS was significantly longer in patients with a high expression of SIRT1. This evidence concerns the gene SIRT1 and breast carcinoma.